V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214264 | 20155170 | 1.7 | 115 | Palliative (P) | 2020-08-05 | 2020-08-06 | ECX | 02 | N | ECX | 100963251 |
| 20214265 | 20155171 | null | 45.6 | Palliative (P) | 2019-08-27 | 2019-09-15 | null | 02 | N | ECX | 100611996 |
| 20214268 | 20155172 | 1.6 | 85 | null | 2020-12-09 | 2020-12-09 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101005444 |
| 20214269 | 20155173 | 1.62 | 70.3 | Neo-adjuvant (N) | 2015-09-20 | 2016-09-10 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100038495 |
| 20214271 | 20155174 | 1.66 | null | null | 2019-06-16 | 2019-06-24 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100854519 |
| 20214272 | 20155175 | 1.63 | 70 | Palliative (P) | 2018-05-30 | 2018-06-13 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 100271370 |
| 20214273 | 20155176 | 1.65 | 48 | Palliative (P) | 2018-11-26 | 2019-11-17 | Panitumumab | 02 | N | PANITUMUMAB | 101018681 |
| 20214274 | 20155177 | 1.55 | 44.8 | null | 2020-01-27 | 2020-01-28 | null | N | Y | CISPLATIN + FLUOROURACIL | 101550365 |
| 20214277 | 20155178 | 1.75 | 67.8 | Palliative (P) | 2020-07-09 | 2020-07-09 | null | 02 | N | PANITUMUMAB | 101053354 |
| 20214278 | 20155179 | 1.6 | 85.2 | Curative (C) | 2019-09-15 | 2019-10-11 | null | 2 | N | CARBOPLATIN + ETOPOSIDE | 101800908 |
| 20214280 | 20155180 | 1.79 | 68.2 | Neo-adjuvant (N) | 2017-10-02 | 2017-10-11 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101103973 |
| 20214282 | 20155181 | 1.71 | 79.9 | Palliative (P) | 2017-08-19 | 2019-05-15 | ECX | 02 | N | ECX | 101299740 |
| 20214284 | 20155182 | null | null | Neo-adjuvant (N) | 2017-01-26 | 2017-01-30 | ECX | N | N | ECX | 101471835 |
| 20214287 | 20155183 | 1.81 | 59 | Palliative (P) | 2017-12-29 | 2017-12-31 | null | 2 | N | ECX | 101290414 |
| 20214293 | 20155184 | 1.7 | null | Palliative (P) | null | 2018-09-19 | null | 02 | N | ECX | 100326594 |
| 20214302 | 20155185 | 1.63 | 61.2 | Palliative (P) | 2019-09-01 | 2019-09-03 | null | 02 | N | NIVOLUMAB | 101047594 |
| 20214304 | 20155186 | 1.85 | 94.95 | Adjuvant (A) | null | 2016-08-13 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100361010 |
| 20214305 | 20155187 | 1.84 | 67.2 | Palliative (P) | 2016-12-09 | 2016-12-10 | ECX | N | N | ECX | 100914794 |
| 20214315 | 20155189 | 1.78 | null | Palliative (P) | 2021-07-04 | 2021-07-19 | NIVOLUMAB | 02 | Y | NIVOLUMAB | 101861415 |
| 20214318 | 20155190 | 1.69 | 48.25 | Neo-adjuvant (N) | 2020-04-22 | 2020-04-26 | Panitumumab | 02 | Y | PANITUMUMAB | 101380634 |
| 20214319 | 20155191 | 1.77 | 52.2 | Palliative (P) | 2021-01-02 | 2021-03-19 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101152431 |
| 20214325 | 20155192 | 1.61 | 77 | null | null | 2019-05-12 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 101816293 |
| 20214326 | 20155193 | null | null | Neo-adjuvant (N) | 2020-06-02 | 2020-06-05 | ECX | N | N | ECX | 101082702 |
| 20214327 | 20155194 | 1.78 | 75.6 | Palliative (P) | 2021-08-01 | 2021-08-22 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101542315 |
| 20214328 | 20155195 | 1.56 | 77.4 | null | 2017-12-21 | 2018-01-02 | null | 02 | null | PANITUMUMAB | 100593973 |
| 20214331 | 20155196 | null | 81.6 | null | 2010-11-02 | 2012-03-09 | CISPLATIN + FLUOROURACIL | null | null | CISPLATIN + FLUOROURACIL | 101098727 |
| 20214332 | 20155197 | null | 74.2 | Palliative (P) | 2016-07-28 | 2016-10-27 | ECX | 02 | N | ECX | 100579633 |
| 20214337 | 20155198 | 1.58 | 35.4 | null | null | 2019-10-19 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100617183 |
| 20214338 | 20155199 | 1.73 | null | Palliative (P) | null | 2021-11-30 | null | 02 | null | PANITUMUMAB | 100085954 |
| 20214343 | 20155200 | 0 | null | Palliative (P) | 2021-01-09 | 2021-01-09 | Carboplatin + Etoposide iv&po | null | N | PANITUMUMAB | 101292578 |
| 20214349 | 20155201 | 1.72 | 67 | null | null | 2020-05-31 | null | 2 | N | CISPLATIN + FLUOROURACIL | 101202817 |
| 20214357 | 20155204 | 1.59 | 84.7 | Neo-adjuvant (N) | 2018-12-05 | 2018-12-17 | null | 02 | N | NIVOLUMAB | 100501724 |
| 20214360 | 20155205 | 1.71 | 45 | null | null | 2019-07-16 | ECX | 02 | null | ECX | 101790358 |
| 20214361 | 20155206 | 1.61 | null | Curative (C) | 2019-03-13 | 2019-05-31 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101585538 |
| 20214362 | 20155207 | 1.78 | null | Neo-adjuvant (N) | 2018-08-02 | 2018-08-08 | Panitumumab | null | N | PANITUMUMAB | 101745274 |
| 20214363 | 20155208 | 1.77 | 64.4 | Palliative (P) | 2018-06-05 | 2018-06-29 | null | N | N | PANITUMUMAB | 101134149 |
| 20214364 | 20155209 | 1.79 | 63 | Curative (C) | 2018-02-25 | 2018-03-15 | null | 02 | N | ECX | 101613455 |
| 20214366 | 20155210 | 1.57 | 67.58 | null | 2022-02-10 | 2022-02-26 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101259361 |
| 20214367 | 20155211 | 1.62 | 62.7 | null | 2016-09-10 | 2016-09-24 | null | 02 | null | NIVOLUMAB | 100259294 |
| 20214373 | 20155213 | 1.7 | 75.6 | null | null | 2021-07-27 | null | null | N | CARBOPLATIN + ETOPOSIDE | 100971146 |
| 20214374 | 20155214 | 1.73 | null | Palliative (P) | 2016-12-13 | 2016-12-16 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100371394 |
| 20214376 | 20155216 | 1.59 | 46.8 | null | 2018-11-29 | 2018-12-06 | null | 02 | N | ECX | 100706747 |
| 20214378 | 20155217 | 1.7 | 69.6 | Curative (C) | 2017-06-09 | 2017-07-06 | Panitumumab | 02 | null | PANITUMUMAB | 100764959 |
| 20214380 | 20155218 | 1.7 | 70 | null | 2021-05-11 | 2021-05-25 | CISPLATIN + FLUOROURACIL | null | null | CISPLATIN + FLUOROURACIL | 101707416 |
| 20214383 | 20155220 | null | 87 | null | 2021-05-30 | 2021-06-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100238147 |
| 20214384 | 20155221 | 1.63 | 57.7 | Adjuvant (A) | 2021-01-05 | 2021-01-19 | null | 02 | Y | NIVOLUMAB | 101004453 |
| 20214388 | 20155222 | 1.6 | 54.6 | null | 2021-05-29 | 2021-05-30 | ECX | 02 | null | ECX | 100756555 |
| 20214392 | 20155223 | 1.65 | 121.8 | null | 2021-07-15 | 2021-07-15 | Panitumumab | N | null | PANITUMUMAB | 100407029 |
| 20214393 | 20155224 | 1.63 | 63.2 | Neo-adjuvant (N) | 2018-03-05 | 2018-03-12 | Panitumumab | 02 | N | PANITUMUMAB | 100994666 |
| 20214395 | 20155225 | 1.61 | 51.5 | Neo-adjuvant (N) | 2018-09-05 | 2018-09-18 | CISPLATIN + FLUOROURACIL + RT | N | N | CISPLATIN + FLUOROURACIL | 100069783 |